Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data

Didier Meulendijks, Linda M Henricks, Gabe S Sonke, Maarten J Deenen, Tanja K Froehlich, Ursula Amstutz, Carlo R Largiadèr, Barbara A Jennings, Anthony M Marinaki, Jeremy D Sanderson, Zdenek Kleibl, Petra Kleiblova, Matthias Schwab, Ulrich M Zanger, Claire Palles, Ian Tomlinson, Eva Gross, André B P Van Kuilenburg, Cornelis J A Punt, Miriam KoopmanJos H Beijnen, Annemieke Cats, Jan H M Schellens

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1639-1650
JournalThe Lancet Oncology
Volume16
Issue number16
DOIs
Publication statusPublished - 1 Dec 2015

Cite this